Mosbrooker Eric
Chief Commercial Officer at Avidity Biosciences, Inc.
- Sold, on record
- $6.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 3, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Avidity Biosciences, Inc.Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Avidity Biosciences, Inc.NoticeAug 6, 2025 2025
Filed to sell 130,807 shares ($5M)
Mosbrooker Eric, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Avidity Biosciences, Inc.RoutineAug 6, 2025 same day
Sold 130,807 shares at $44.06 ($5.8M)
Mosbrooker Eric, Chief Commercial Officer
10b5-1 planSold 70.4% of holdings ($8.2M position)55,000 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice Avidity Biosciences, Inc.NoticeSep 3, 2025 +28 days
Filed to sell 19,688 shares ($930k)
Mosbrooker Eric, Officer
10b5-1 planFiling
- 4 Form 4 sale Avidity Biosciences, Inc.RoutineSep 3, 2025 same day
Sold 6,563 shares at $47.07 ($309k)
Mosbrooker Eric, Chief Commercial Officer
10b5-1 planSold 10.7% of holdings ($2.9M position)55,000 shares leftFollows a Form 144Filing
- 5 Form 4 sale Avidity Biosciences, Inc.RoutineOct 3, 2025 +30 days
Sold 6,562 shares at $45.38 ($298k)
Mosbrooker Eric, Chief Commercial Officer
10b5-1 planSold 10.7% of holdings ($2.8M position)55,000 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2025 | Oct 7, 2025 | Avidity Biosciences, Inc. | Chief Commercial Officer | Form 4 sale | 6,562 | $298k | 10.7% | Routine | SEC |
| Sep 3, 2025 | Sep 5, 2025 | Avidity Biosciences, Inc. | Chief Commercial Officer | Form 4 sale | 6,563 | $309k | 10.7% | Routine | SEC |
| Sep 3, 2025 | Sep 3, 2025 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 19,688 | $930k | Notice | SEC | |
| Aug 6, 2025 | Aug 8, 2025 | Avidity Biosciences, Inc. | Chief Commercial Officer | Form 4 sale | 130,807 | $5.8M | 70.4% | Routine | SEC |
| Aug 6, 2025 | Aug 6, 2025 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 130,807 | $5M | Notice | SEC |